ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

$25 Million In Federal Aid to Jackson Laboratory approved By Senate; NIH, Natcher Are Opposed

August 11, 1989

Concepts Approved For New Technology In Computers, Recompetition

November 6, 1987

Time Spent Sitting Associated With Total Mortality, Study Finds

July 30, 2010

FDA Approves Avastin Combination For Late-Stage Cervical Cancer

August 29, 2014

ACS Did Not Sign Bumpers Letter

May 1, 1992

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010